Abliva
Search results
Scope
Date
~
-
Bio & PharmaYungjin Pharm's new drug candidate gets Fast Track from FDA
South Korea's Yungjin Pharm has secured Fast Track designation from the US Food and Drug Administration (FDA) for its new drug candidate KL1333, des...
Sep 06, 2023 (Gmt+09:00)
1
Latest News
- 1 MBK-invested Homeplus looks for new owner as M&A emerges as option
- 2 Hyundai Steel to displace Baoshan as GM Korea's supplier
- 3 S.Korea’s No.1 dried seaweed firm Kwangcheonkim on market for $295 mn
- 4 BOK chief warns against aggressive policy rate cuts, sees need for fiscal stimulus
- 5 S.Korea eases path for foreign REITs in senior housing push
